ADVERTISEMENT

 

Press Releases

 

7

Mar

2024

FDA panel recommends trivalent flu vaccine for next fall

Author: Anonym

FDA’s Vaccines and Related Biological Products Advisory Committee recommended that regulators drop the quadrivalent influenza vaccines used for roughly the past decade or so in favor of a trivalent replacement.

Comments (0)
Number of views (2706)
Article rating: No rating
Read more

Categories: APhA News

Tags: APhA News

23

Feb

2024

Age-related risk of serious falls increases with opioid use

Author: Anonym

New research published in JAMA Internal Medicine shows that opioid analgesics elevate the likelihood of falls in all adult patients, but the greatest risk is among individuals aged 85 years and older.

Comments (0)
Number of views (2892)
Article rating: No rating
Read more

Categories: APhA News

Tags: APhA News

23

Feb

2024

FDA warns patients not to use smartwatches or smart rings to measure blood glucose levels

Author: Anonym

FDA released a safety alert February 21 warning patients about the dangers of smartwatches or smart rings that claim to gauge blood glucose levels without requiring the user to pierce their skin.

Comments (0)
Number of views (3110)
Article rating: No rating
Read more

Categories: APhA News

Tags: APhA News

20

Feb

2024

Researchers tease out benefit of HPV vaccine based on dose and age group

Author: Anonym

Findings from a new population-based study found that no matter how many doses of bivalent HPV vaccine were administered, no woman who received the HPV bivalent vaccine at age 12 or 13 years developed invasive cancer later.

Comments (0)
Number of views (4396)
Article rating: No rating
Read more

Categories: APhA News

Tags: APhA News

16

Feb

2024

CDC seeks to expand University of Michigan’s pharmacist hypertension program across U.S.

Author: Anonym

According to CDC's recent assessment of the University of Michigan’s Hypertension Pharmacists’ Program (HPP), 66% of patients who consulted with an HPP pharmacist brought their disease under control within 3 months compared with 42% of patients who did not meet with a pharmacist. At 6 months, 69% had their BP under control compared with 56% of nonparticipants.

Comments (0)
Number of views (4864)
Article rating: 5.0
Read more

Categories: APhA News

Tags: APhA News

RSS
First45679111213Last
Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT